Antitumor activity of electrospun polylactide nanofibers loaded with 5-fluorouracil and oxaliplatin against colorectal cancer

被引:73
|
作者
Zhang, Jiayu [1 ]
Wang, Xue [1 ]
Liu, Tongjun [1 ]
Liu, Shi [2 ]
Jing, Xiabin [2 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Changchun 130023, Peoples R China
[2] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China
基金
中国国家自然科学基金;
关键词
Colorectal cancer; electrospinning; local chemotherapy; nanofibers; polylactide; INDUCED PERIPHERAL NEUROPATHY; ACID) COMPOSITE NANOFIBERS; DRUG-DELIVERY SYSTEMS; ANTIBACTERIAL ACTIVITY; CHEMOTHERAPY; AMOXICILLIN; EFFICACY; TUMOR;
D O I
10.3109/10717544.2014.916768
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to evaluate both in vitro and in vivo anticancer activities against colorectal cancer (CRC) of electrospun polylactide (PLA) nanofibers loaded with 5-fluorouracil (5-Flu) and oxaliplatin. For in vitro evaluation, human CRC HCT8 cells were directly exposed to the drug-loaded fiber mats, followed with MTT and flow cytometry (FCM) assay. For in vivo evaluation, the drug-loaded fiber mats were locally implanted into mouse colorectal CT26 tumor-bearing mice, followed with histological analysis and detection of survival rate. The results showed that the drug-loaded fiber mats was similar to that of the combination of free 5-Flu and oxaliplatin in vitro cytotoxicity but was much superior to intravenous injection of free drug in vivo anticancer activities, presenting with suppressed tumor growth rate and prolonged survival time of mice. In conclusion, anticancer activities of 5-Flu and oxaliplatin against CRC can be significantly improved by using PLA electrospun nanofibers as local drug delivery system.
引用
收藏
页码:794 / 800
页数:7
相关论文
共 50 条
  • [41] Oxaliplatin (LOHP) and 5-fluorouracil (5-FU) synergism in advanced colorectal cancer patients (ACRC)
    Meyer, V
    Delva, R
    Gamelin, E
    Lamezec, B
    Maillart, P
    DanquechinDorval, E
    Lortholary, A
    BoisdronCelle, M
    Maigre, M
    Brienza, S
    Cvitkovic, E
    Larra, F
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 746 - 746
  • [42] Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer
    Shakibaei, Mehdi
    Kraehe, Patricia
    Popper, Bastian
    Shayan, Parviz
    Goel, Ajay
    Buhrmann, Constanze
    [J]. BMC CANCER, 2015, 15
  • [43] Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer
    Mehdi Shakibaei
    Patricia Kraehe
    Bastian Popper
    Parviz Shayan
    Ajay Goel
    Constanze Buhrmann
    [J]. BMC Cancer, 15
  • [44] Clinical Study of Combining Chemotherapy of Oxaliplatin or 5-Fluorouracil/Leucovorin with Hydroxycamptothecine for Advanced Colorectal Cancer
    Yuanjue Sun Hui Zhao Yaowu Guo Feng Lin Lina Tang Yang Yao Department of Medical Oncology
    [J]. Cancer Biology & Medicine, 2009, 6 (02) : 117 - 123
  • [45] Oxaliplatin combined to 5-fluorouracil and folinic acid: an effective therapy in patients with advanced colorectal cancer
    Gerard, B
    Bleiberg, H
    Van Daele, D
    Gil, T
    Hendlisz, A
    Di Leo, A
    Fernez, B
    Brienza, S
    [J]. ANTI-CANCER DRUGS, 1998, 9 (04) : 301 - 305
  • [46] Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer
    Recchia, F
    Rea, S
    Nuzzo, A
    Lalli, A
    Di Lullo, L
    De Filippis, S
    Saggio, G
    Biondi, E
    Massa, E
    Mantovani, G
    [J]. ANTICANCER RESEARCH, 2004, 24 (3B) : 1935 - 1940
  • [47] Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer -: A feasibility pilot study
    Calvo, E
    Cortés, J
    González-Cao, M
    Rodríguez, J
    Aramendía, JM
    Fernández-Hidalgo, O
    Martín-Algarra, S
    Salgado, JE
    Martínez-Monge, R
    de Irala, J
    Brugarolas, A
    [J]. ONCOLOGY, 2002, 63 (03) : 254 - 265
  • [48] Dose intensity of oxaliplatin in 5-fluorouracil and leucovorin regimens in pretreated metastatic colorectal cancer.
    Jeong, KJ
    Oh, JM
    Choi, SK
    Oh, D
    [J]. PHARMACOTHERAPY, 2002, 22 (10): : 1356 - 1356
  • [49] A potential predictive model for oxaliplatin plus 5-fluorouracil response in advanced colorectal cancer patients
    Gu, Junjie
    Li, Zhe
    Luo, Fei
    Zhou, Jianfeng
    Sun, Zhao
    Bai, Chunmei
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [50] In vitro and in vivo antitumor effect of HDAC inhibitor in combination with irinotecan, 5-fluorouracil or oxaliplatin in colon cancer
    Na, Young-Soon
    Kim, Tae Won
    Park, Hyo Suk
    Lee, Jae-Lyun
    Ro, Seonggu
    Kim, Jin Cheon
    Lee, Jung Shin
    Jang, Se Jin
    [J]. CANCER RESEARCH, 2009, 69